IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 1176-1200 out of 1259.

<< < 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 > >>

Public Release: 8-Apr-2014
American Association for Cancer Research (AACR) Annual Meeting 2014
Fox Chase study identifies the process in which heat shock protein 90 contributes to metastases in ovarian cancer
By incapacitating the activities of a protein that guides other proteins to fold into a stable shapes, Fox Chase Cancer Center researchers shut off the spigot for two proteases that help ovarian cancer cells chew their way out of the tissue they grow in and dig in at new locations.

Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-815-7828
Fox Chase Cancer Center

Public Release: 8-Apr-2014
American Association for Cancer Research (AACR) Annual Meeting 2014
Phase II trial of efatutazone shows challenge of matching treatment to population
Work at the University of Colorado Cancer Center led to phase II trial of efatutazone with erlotinib in patients with refractory non-small cell lung cancer. Results are reported today at the American Association for Cancer Research Annual Meeting 2014. While efatutazone did not improve the efficacy of erlotinib in this trial, researchers hope lessons from the trial will allow them to make better future use of the drug or other drugs in its class.

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver

Public Release: 8-Apr-2014
Health Affairs
Global health funding reaches new high as funding priorities shift
Global health funding hit an all-time high of $31.3 billion in 2013, five times greater than in 1990. Yet with 3.9 percent growth from 2012 to 2013, the year-over-year increase falls short of the rapid rates seen over the previous decade, according to new research by the Institute for Health Metrics and Evaluation at the University of Washington being published online in a web first edition on Apr. 8 by Health Affairs.

Contact: Rhonda Stewart
stewartr@uw.edu
206-897-2863
Institute for Health Metrics and Evaluation

Public Release: 8-Apr-2014
JAMA
Chemotherapy may be better for certain patients with advanced lung cancer
Among patients with advanced non-small cell lung cancer without a mutation of a certain gene, conventional chemotherapy, compared with treatment using epidermal growth factor receptor tyrosine kinase inhibitors, was associated with improvement in survival without progression of the cancer, but not with overall survival, according to a study in the April 9 issue of JAMA.

Contact: Dong-Wan Kim
kimdw@snu.ac.kr
The JAMA Network Journals

Public Release: 7-Apr-2014
Nature Immunology
La Jolla Institute discovers new mechanism for unleashing immune system against cancer
A major discovery that brings a new drug target to the increasingly exciting landscape of cancer immunotherapy was published yesterday by researchers from La Jolla Institute for Allergy and Immunology and their collaborators from other institutes.
National Institutes of Health

Contact: Bonnie Ward
contact@liai.org
619-303-3160
La Jolla Institute for Allergy and Immunology

Public Release: 7-Apr-2014
American Association for Cancer Research (AACR) Annual Meeting 2014
Milk thistle extract, silibinin, reduces self-renewal of colorectal cancer stem cells
A University of Colorado Cancer Center study presented today at the American Association for Cancer Research Annual Meeting 2014 shows that the chemical silibinin, purified from milk thistle extract, affects cell signaling associated with inflammation and thus also the formation and survival of colorectal cancer stem cells.

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver

Public Release: 7-Apr-2014
Annals of Internal Medicine
Annals of Internal Medicine tip sheet for April 8, 2014
This release contains information about articles being published in Annals of Internal Medicine on April 8, including 'Daily low-dose aspirin may protect against preeclampsia complications' and 'Could controversial Canadian mammography study spark new thinking in the US?'

Contact: Megan Hanks
mhanks@acponline.org
215-351-2656
American College of Physicians

Public Release: 7-Apr-2014
American Association for Cancer Research (AACR) Annual Meeting 2014
Research yields potential target for epithelial ovarian cancer treatment
Fox Chase Cancer Center researchers who are investigating the biological mechanisms behind metastatic epithelial ovarian cancer recently found that an enzyme called focal adhesive kinase can play a critical -- and previously unstudied -- role in the growth and spread of the disease. The research will be presented on Monday, April 7, at the American Association for Cancer Research Annual Meeting 2014.

Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-815-7828
Fox Chase Cancer Center

Public Release: 7-Apr-2014
American Association for Cancer Research (AACR) Annual Meeting 2014
Proceedings of the National Academy of Sciences
For good and ill, immune response to cancer cuts both ways
The difference between an immune response that kills cancer cells and one that conversely stimulates tumor growth can be as narrow as a 'double-edged sword,' report researchers at the University of California San Diego School of Medicine in the April 7, 2014, online issue of the Proceedings of the National Academy of Sciences.
Samuel and Ruth Engelberg Fellowship at the Cancer Research Institute

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego

Public Release: 7-Apr-2014
American Association for Cancer Research (AACR) Annual Meeting 2014
Gold nanorods attach to, kill bladder cancer cells
A University of Colorado Cancer Center study presented today at the American Association for Cancer Research Annual Meeting 2014 demonstrates a novel strategy that accomplishes both: bladder cancer cells overexpress the protein EGFR; gold nanorods can be engineered to attach to EGFR proteins; and then the application of low-intensity laser to the tissue can preferentially heat these gold nanorods, killing the EGFR-rich cancer cells to which they are attached.

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver

Public Release: 7-Apr-2014
American Association for Cancer Research (AACR) Annual Meeting 2014
Studies reveal more clues on how pregnancy protects against breast cancer
Scientists at Fox Chase Cancer Center have unearthed new clues about how pregnancy reduces women's risk of developing breast cancer. The research will be presented at the American Association for Cancer Research Annual Meeting 2014.

Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-815-7828
Fox Chase Cancer Center

Public Release: 7-Apr-2014
Proceedings of the National Academy of Sciences
Well-known cancer gene NRAS produces 5 variants, study finds
A new study shows that the NRAS gene, known to play a fundamental role in cancer development, produces five gene variants, or isoforms, rather than just one form, as thought. The study identified four previously unknown variants that the NRAS gene produces. The finding might help improve drugs for cancers in which NRAS plays a crucial role. It also suggests that NRAS might affect additional target molecules in cells.
NIH/National Cancer Institute, Coleman Leukemia Research Foundation, Pelotonia Fellowship Program

Contact: Darrell E. Ward
Darrell.Ward@osumc.edu
614-293-3737
Ohio State University Wexner Medical Center

Public Release: 7-Apr-2014
29th Annual EAU Congress
New method for prostate cancer detection can save millions of men painful examination
Each year prostate tissue samples are taken from over a million men -- in most cases using 12 large biopsy needles -- to check whether they have prostate cancer. This procedure, which was recently described by an American urology professor as 'barbaric,' shows that 70 percent of the subjects do not have cancer. A patient-friendly examination, which drastically reduces the need for biopsies has been developed at Eindhoven University of Technology, together with AMC Amsterdam.
European Research Council, KWF Dutch Cancer Foundation, Netherlands Organisation for Scientific Research

Contact: Massimo Mischi
m.mischi@tue.nl
31-613-269-039
Eindhoven University of Technology

Public Release: 7-Apr-2014
Surgery
Tissue testing during breast cancer lumpectomies
Unique laboratory testing during breast cancer lumpectomies to make sure surgeons remove all cancerous tissue spares patients the need for a repeat lumpectomy in roughly 96 percent of cases at Mayo Clinic in Rochester, a success rate much higher than the rate nationally, a Mayo study shows.
Mayo Clinic

Contact: Sharon Theimer
newsbureau@mayo.edu
507-284-5005
Mayo Clinic

Public Release: 7-Apr-2014
American Association for Cancer Research (AACR) Annual Meeting 2014
New breast cancer results illustrate promise and potential of I-SPY 2 trial
In an innovative clinical trial led by UC San Francisco, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed, high-risk breast cancer.

Contact: Elizabeth Fernandez
elizabeth.fernandez@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 7-Apr-2014
European Urology
Henry Ford Hospital cited: World's first surgical innovators for patient safety standards
An innovative kidney transplant technique developed by Henry Ford Hospital is credited as the first in the world to use a new set of patient safety standards coordinated by the University of Oxford in England. The standards are being assembled and offered as a framework for developing, performing and reporting surgical innovations that, unlike new medical treatments, are not under strict regulations and control.

Contact: Dwight Angell
dwight.angell@hfhs.org
313-850-3471
Henry Ford Health System

Public Release: 7-Apr-2014
Nature Communications
Novel plant biotechnology approach for sustainable production of pharmaceutical compounds
European scientists have made ground-breaking discoveries for improving the efficiency of the production of pharmaceuticals through plant biotechnology.
European Commission

Contact: Dr. Kirsi-Marja Oksman-Caldentey
kirsi-marja.oksman@vtt.fi
358-207-224-459
VTT Technical Research Centre of Finland

Public Release: 7-Apr-2014
American Association for Cancer Research (AACR) Annual Meeting 2014
Disruption of VISTA plays an important role in regulating immune response
Researchers at the Geisel School of Medicine at Dartmouth have found that the body's immune system response was enhanced when they disrupted VISTA, a protein that prevents the immune system from overreacting. Understanding how checkpoint regulators like VISTA function is important to cancer researchers, who hope to use the immune system to attack tumors.
National Institutes of Health, Hitchcock Foundation, Melanoma Research Foundation, Wellcome Trust, Medical Research Council Centre for Transplantation and Biomedical Research Center at King's College London

Contact: Robin Dutcher
robin.Dutcher@hitchcock.org
603-653-9056
The Geisel School of Medicine at Dartmouth

Public Release: 6-Apr-2014
ESTRO 33
Six months hormone therapy in addition to radiotherapy improves prostate cancer survival
Men with prostate cancer that is small and confined to the prostate gland but that is at risk of growing and spreading, do better if they are treated with radiotherapy combined with androgen deprivation therapy, which lowers their levels of the male hormone, testosterone, according to new research to be presented at the 33rd conference of the European Society for Radiotherapy and Oncology in Vienna. The findings are expected to change clinical practice.
European Organisation for Research and Treatment of Cancer, EORTC Foundation, AstraZeneca

Contact: Emma Mason
wordmason@mac.com
European Society for Radiotherapy and Oncology (ESTRO)

Public Release: 6-Apr-2014
ESTRO 33
Increased risk of developing lung cancer after radiotherapy for breast cancer
Women who have radiotherapy for breast cancer have a small but significantly increased risk of subsequently developing a primary lung tumor, and now research has shown that this risk increases with the amount of radiation absorbed by the tissue. The research will be presented at the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna.

Contact: Emma Mason
wordmason@mac.com
European Society for Radiotherapy and Oncology (ESTRO)

Public Release: 6-Apr-2014
Nature Medicine
Blood test could provide rapid, accurate method of detecting solid cancers
A blood sample could one day be enough to diagnose many types of solid cancers, or to monitor the amount of cancer in a patient's body and responses to treatment. Now, researchers at the Stanford University School of Medicine have devised a way to quickly bring the technique to the clinic.

Contact: Krista Conger
kristac@stanford.edu
650-725-5371
Stanford University Medical Center

Public Release: 6-Apr-2014
American Association for Cancer Research (AACR) Annual Meeting 2014
Researchers find that renal cancer cells thrive when put in the right environment and supported by a specific enzyme
Tumor cells are picky about where they live. In the wrong environment, they fail to reach their potential. But put those same cells on the right bit of real estate, and they grow like mad. Researchers at Fox Chase Cancer Center found renal cancer cells planted in a supportive environment proliferate with the help of an enzyme usually only seen in the brain.

Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-815-7828
Fox Chase Cancer Center

Public Release: 6-Apr-2014
Nature Genetics
Gene sequencing project discovers mutations tied to deadly brain tumors in young children
The St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project has identified new mutations in pediatric brain tumors known as high-grade gliomas, which most often occur in the youngest patients. The research appears today as an advance online publication in the scientific journal Nature Genetics.
Pediatric Cancer Genome Project, Kay Jewelers, National Institutes of Health, Cure Starts Now Found, Smile for Sophie Forever Found

Contact: Carrie Strehlau
carrie.strehau@stjude.org
901-595-2295
St. Jude Children's Research Hospital

Public Release: 6-Apr-2014
American Association for Cancer Research (AACR) Annual Meeting 2014
Scaffolding protein promotes growth and metastases of epithelial ovarian cancer
Researchers from Fox Chase Cancer Center have shown that NEDD9, a scaffolding protein responsible for regulating signaling pathways in the cell, promotes the growth and spread of epithelial ovarian cancer.

Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-815-7828
Fox Chase Cancer Center

Public Release: 6-Apr-2014
BJU International
Circumcision could prevent prostate cancer... if it's performed after the age of 35
Researchers at the University of Montreal and the Institut National de la Recherche Scientifique-Institut-Armand-Frappier have shown that men circumcised after the age of 35 were 45 percent less at risk of later developing prostate cancer than uncircumcised men.
Cancer Research Society, Ministère du Développement économique, de l'Innovation et de l'Exportation, Fonds de recherche du Québec Santé

Contact: William Raillant-Clark
w.raillant-clark@umontreal.ca
514-566-3813
University of Montreal

Showing releases 1176-1200 out of 1259.

<< < 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 > >>

  Search News Releases

     

 

EurekAlert!